Yan'an Bikang disclosed the first quarterly report of 2022, realizing revenue of 2.259 billion yuan

On July 7, Capital State learned that the A -share listed company Yan'an Bikang (code: 002411.sz) released the first quarter performance report of 2022.

From January 1, 2022-March 31, 2022, the company realized operating income of 2.259 billion yuan, an increase of 56.46%year-on-year, and net profit was 270 million yuan, an increase of 137.04%year-on-year, and the basic earnings per share were 0.18 yuan.

The company's industry is chemical pharmaceutical.

During the company's reporting period, the total assets at the end of the period were 19.164 billion yuan, the operating profit was 445 million yuan, the accounts receivable were 3.823 billion yuan, and the net cash flow generated by operating activities was 40.375 million yuan.Cash is 1360 million yuan.

Yan'an Bikang, the company's full name Yan'an Pharmaceutical Co., Ltd., was established on December 30, 2002. The current general manager Shao Xinjun.4 categories: pharmaceutical intermediate and pesticide intermediate) section.

- END -